J&J may prune its agencies

Share this content:

Johnson & Johnson may consolidate advertising and marketing for its pharmaceutical brands into one or two companies, a company spokesperson told Medical Marketing and Media, a sister publication. J&J is currently conducting a global review of its pharma agencies. The 250-plus companies are scattered across more than 50 countries.